Trials / Completed
CompletedNCT02217436
iPad as a Distraction Tool During Facial Laceration Repair
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- University of California, San Diego · Academic / Other
- Sex
- All
- Age
- 2 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
Children aged 2-12 presenting to the Rady Children's Hospital San Diego (RCHSD) emergency department with facial lacerations requiring suture repair will be eligible to participate in the study. Participating children will be randomized to standard care versus standard care plus iPad use during the procedure. Children's anxiety levels assessed using a validated scale will be measured from video recordings made of the procedure. Parent and provider satisfaction surveys will be completed following the procedure. The primary study aim is to determine how iPad use affects children's anxiety levels during facial laceration repair. The secondary study aim is to determine how iPad use affects parent and provider satisfaction regarding a child's facial laceration repair. Hypothesis is that iPad use decreases children's anxiety levels during facial laceration repair and increases parent and provider satisfaction regarding a child's facial laceration repair.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | iPad | iPad with age-appropriate applications, videos, and music |
| OTHER | Standard Care | All study participants will receive standard care, which consists of procedural explanation and preparation by providers, verbal encouragement and comforting by providers and parents, and topical anesthetic (LET) followed by injectable lidocaine administration (whether one or both of these anesthetics will be used will be determined by the provider prior to randomization). |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2014-08-15
- Last updated
- 2019-07-23
- Results posted
- 2019-07-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02217436. Inclusion in this directory is not an endorsement.